Daxin Pharmaceuticals Private Limited, a active private limited company, was established on 06 February 2014 in New Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24100DL2014PTC264559. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹9.84 Cr.
It upholds a compliant status. Employing 78 professional, Its leadership includes Sheela Jha (Director), Nikhil Kumar Jha (Director). Past directors included Anand Kumar Jha. It holds ₹30.55 Cr open charges and ₹1.95 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Office No-204, 205, 2Nd Floor, Apra Dwarka Plaza-I, Plot No-21, Sector-10, Dwarka, New Delhi, Delhi, 110075.
U24100DL2014PTC264559
264559
06 February 2014
₹10.00 Cr
₹9.84 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Daxin Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sheela Jha | Director | 06 Feb 2014 | Current |
| Nikhil Kumar Jha | Director | 16 Feb 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 16 Feb 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Daxin Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 22.14% increase. The company also saw a substantial improvement in profitability, with a 1388.04% increase in profit. The company's net worth Soared by an impressive increase of 14.68%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Daxin Pharmaceuticals had a promoter holding of 56.73% and a public holding of 43.27%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹305,497,000.00
₹19,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Apr 2024 | Others | ₹3.30 M | Open |
| 25 Nov 2021 | Others | ₹1.05 Cr | Open |
| 20 Nov 2020 | Others | ₹29.17 Cr | Open |
| 30 May 2015 | Others | ₹1.95 Cr | Satisfied |
Explore comprehensive loan charge details -
Daxin Pharmaceuticals has a workforce of 78 employees as of Mar 24, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Daxin Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Daxin Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Others of Rs. 29.17 Cr registered on 20 Nov 2020 with Charge ID 100402828 was modified on 03 Jun 2025. was completed.
Progress on Daxin Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on A charge with Others amounted to Rs. 0.33 Cr with Charge ID 100913441 was registered on 20 Apr 2024. was documented.
Daxin Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
The activity A charge registered on 30 May 2015 via Charge ID 10578019 with Others was fully satisfied on 04 Jan 2024. was completed.
The activity A charge with Others amounted to Rs. 1.05 Cr with Charge ID 100504861 was registered on 25 Nov 2021. was completed.
The CIN of Daxin Pharmaceuticals Private Limited is U24100DL2014PTC264559.
Daxin Pharmaceuticals Private Limited is headquartered at Office No-204, 205, 2Nd Floor, Apra Dwarka Plaza-I, Plot No-21, Sector-10, Dwarka, New Delhi, Delhi, 110075.
Daxin Pharmaceuticals Private Limited was incorporated on 06 February 2014.
The current directors of Daxin Pharmaceuticals Private Limited are
The primary industry of Daxin Pharmaceuticals Private Limited is Manufacturing.
Daxin Pharmaceuticals Private Limited is unlisted.
The authorized capital of Daxin Pharmaceuticals Private Limited is ₹10.00 Cr, and the paid-up capital is ₹9.84 Cr.
The compliance status of Daxin Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX